Altered hemostasis in migraineurs studied with a dynamic flow system

Thrombosis Research

Volumn 119, Issue 2, 2007, Pages 217-222

  Tietjen, Gretchen E ^a   Al Qasmi, Mohamed M ^a   Athanas, Kathleen ^a   Utley, Christine ^a   Herial, Nabeel A ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Clot Signature Analyzer; Hemostasis; Livedo reticularis; Migraine; von Willebrand factor

Indexed keywords

ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; VON WILLEBRAND FACTOR;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING TIME; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; EVALUATION; FLOW CYTOMETRY; HEADACHE; HEMOSTASIS; HUMAN; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MIGRAINE; PATIENT INFORMATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; THROMBOGENESIS;

ADULT; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; SKIN DISEASES, VASCULAR; VASCULAR DISEASES; VON WILLEBRAND FACTOR;

EID: 33751077549     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.12.020     Document Type: Article

References (28)

1. Stang P.E., Carson A.P., Rose K.M., Mo J., Ephross S.A., Shahar E., et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 64 9 (2005) 1573-1577
2. Merikangas K.R., Fenton B.T., Cheng S.H., Stolar M.J., and Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 54 4 (1997) 362-368
3. Joseph R., and Welch K.M. The platelet and migraine: a nonspecific association. Headache 27 7 (1987) 375-380
4. Kovacs K., Herman F., Filep J., Jelencsik I., Magyar K., and Csanda E. Platelet aggregation of migraineurs during and between attacks. Cephalalgia 10 4 (1990) 161-165
5. D'Andrea G., Toldo M., Cortelazzo S., and Milone F.F. Platelet activity in migraine. Headache 22 5 (1982) 207-212
6. Kalendovsky Z., and Austin J.H. "Complicated migraine" its association with increased platelet aggregability and abnormal plasma coagulation factors. Headache 15 1 (1975) 18-35
7. Sadler J.E. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67 (1998) 395-424
8. Mannucci P.M. von Willebrand factor: a marker of endothelial damage?. Arterioscler Thromb Vasc Biol 18 9 (1998) 1359-1362
9. Qizilbash N., Duffy S., Prentice C.R., Boothby M., and Warlow C. Von Willebrand factor and risk of ischemic stroke. Neurology 49 6 (1997) 1552-1556
10. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., and Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96 4 (1997) 1102-1108
11. Folsom A.R., Rosamond W.D., Shahar E., Cooper L.S., Aleksic N., Nieto F.J., et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100 7 (1999) 736-742
12. Cesar J.M., Garcia-Avello A., Vecino A.M., Sastre J.L., and Alvarez-Cermeno J.C. Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand 91 5 (1995) 412-413
13. Tietjen G.E., Al Qasmi M.M., Athanas K., Dafer R.M., and Khuder S.A. Increased von Willebrand factor in migraine. Neurology 57 2 (2001) 334-336
14. Hering-Hanit R., Friedman Z., Schlesinger I., and Ellis M. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 21 2 (2001) 137-139
15. Tietjen G.E., Gottwald L., Al Qasmi M.M., Gunda P., and Khuder S.A. Migraine is associated with livedo reticularis: a prospective study. Headache 42 4 (2002) 263-267
16. Tietjen G.E., Al Qasmi M.M., and Shukairy M.S. Livedo reticularis and migraine: a marker for stroke risk?. Headache 42 5 (2002) 352-355
17. Tietjen GE, Al Qasmi MM, Gunda P, Herial NA. Sneddon's syndrome: another migraine-stroke association? Cephalalgia, doi:10.1111/j.1468-2982.2005.01032.x.
18. Mayou S.C., Kovacs I.B., Ridler C.D., and Kirby J.D. Hemostatic abnormalities in Sneddon's syndrome. Angiology 43 4 (1992) 342-349
19. Matsumura Y., Tomimoto H., Yamamoto M., Imamura S., and Miyachi Y. Sneddon syndrome with multiple cerebral infarctions 12 years after the onset of livedo vasculitis: a possible involvement of platelet activation. J Dermatol 28 9 (2001) 508-510
20. Kalashnikova L.A., Nasonov E.L., Baranov A.A., and Aleksandrova E.N. Sneddon's syndrome and Willebrand's factor antigen. Klin Med (Mosk) 72 3 (1994) 29-32
21. Igawa T., Kornhauser R., Cilla D.D., King J.O., and Kambayashi J. Evaluation of the Clot Signature Analyzer as a hemostasis test in healthy volunteers exposed to low doses of aspirin. Clin Appl Thromb Hemost 5 2 (1999) 117-121
22. Fricke W., Kouides P., Kessler C., Schmaier A.H., Krijanovski Y., Jagadeesan K., et al. A multicenter clinical evaluation of the Clot Signature Analyzer. J Thromb Haemost 2 5 (2004) 763-768
23. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 8 Suppl 7 (1988) 1-96
24. Silberstein S.D., Lipton R.B., and Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47 4 (1996) 871-875
25. Li C.K., Hoffmann T.J., Hsieh P.Y., Malik S., and Watson W.C. The Xylum Clot Signature Analyzer: a dynamic flow system that simulates vascular injury. Thromb Res 92 6 Suppl 2 (1998) S67-S77
26. Raitakari O.T., and Celermajer D.S. Testing for endothelial dysfunction. Ann Med 32 5 (2000) 293-304
27. Kruit M.C., van Buchem M.A., Hofman P.A., Bakkers J.T., Terwindt G.M., Ferrari M.D., et al. Migraine as a risk factor for subclinical brain lesions. JAMA 291 4 (2004) 427-434
28. Scher A.I., Terwindt G.M., Picavet H.S., Verschuren W.M., Ferrari M.D., and Launer L.J. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64 4 (2005) 614-620